BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'COVID-19 How'. (Return)

Google Business NewsJul 10, 2020
Researchers are launching a massive study to tell us how prevalent COVID-19 is in North Texas - The Dallas Morning News
Researchers are launching a massive study to tell us how prevalent COVID-19 is in North Texas  The Dallas Morning NewsCoronavirus in North Texas: How a surge in COVID-19 cases is impacting local hospitals  WFAADog In Texas Confirmed Covid-19 Positive  ForbesTo understand COVID's spread in Dallas-Fort Worth, 45,000 will be tested in study  Fort Worth Star-Telegram

Yahoo BusinessJul 10, 2020
Is United Airlines Stock a Buy Right Now? This Is What You Need To Know
The airline industry has been hit hard by COVID-19. Border closures and shelter in place measures brought the industry to a standstill during the virus' initial wave, as air traffic was grounded across the globe.Whether the pandemic has peaked or not, United Airlines (UAL) upcoming flight schedule acknowledges normality is still a way off. Air travel volume remains weak and currently United's cash burn rate amounts to roughly $40 million a week. As a result, United has issued warnings that almost half of its workforce might be furloughed in the fall.Further keeping air travel rates down are recent measures by New York, New Jersey, and Connecticut which require any travelers from states with COVID-19 test rates above 10% to self-quarantine for two weeks. The measures have resulted in a slew of discount offers from United.However, recent United data shows the promise of low prices is not enough to entice the public while the risk of quarantine still looms. As a result, United's August schedule is expected to drop by 65% compared to last year's capacity. This is lower than the expected 60% drop United were anticipating only a week ago.Still, the latest figures are an improvement on June and July's numbers, which were down year-over-year by 88% and 75%, respectively. United have said the rest of 2020's schedule will probably resemble that of August's.What this means to Deutsche Bank analyst Michael Linenberg, is that more uncertainty lies ahead.The 5-star analyst said, "The bottom line is that, a

KiplingerJul 10, 2020
Stock Market Today: Gilead Gives Stocks a Booster Shot
Gilead Sciences (GILD, 2.2%) once again helped inject a little life into stocks Friday with the help of its coronavirus treatment remdesivir.

The major indices appeared poised for losses in early trading amid another record surge in U.S. COVID-19 cases, as well as yesterday's comments from Treasury Secretary Steven Mnuchin indicating that the White House wants to cap unemployment benefits in the next round of coronavirus stimulus.

65 Best Dividend Stocks You Can Count On in 2020 However, Gilead announced that an analysis of previously released clinical trial data revealed an "important finding": namely, a 62% reduction in mortality risk in coronavirus patients compared to the current standard of care. 

The news was music to Wall Street's ears; financial stocks including JPMorgan Chase (JPM, 5.5%) and Goldman Sachs (GS, 4.5%) contributed to a 1.4% jump in the Dow Jones Industrial Average to 26,075. The S&P 500 finished 1.1% higher to 3,185, while the small-cap Russell 2000 jumped 1.7% to 1,422.

The Nasdaq Composite gained a more modest 0.6%, but that marked a third straight close at record


MarketWatchJul 10, 2020
Business in the Age of COVID-19: Netflix pulled off a showstopper early in the pandemic, but will the sequel deserve the price?
The runaway success of streaming services during the pandemic leads to the invariable entertainment-tinged question: What does Netflix do for an encore?

Yahoo BusinessJul 10, 2020
Texas Hospital Cases Soar; Masks Key in Melbourne: Virus Update
(Bloomberg) -- Texas hospitalizations topped 10,000 for the first time and California suffered its second-highest day of deaths. Florida's biggest county had a record number of patients in its intensive-care units.New York will allow limited visitors into nursing homes and long-term facilities for the first time in months. Overall U.S. cases rose 1.9%, matching the average daily rise over the past week.Gilead Sciences Inc.'s remdesivir treatment reduced the mortality risk for Covid-19 patients by 62% compared to standard care, a new analysis of trial data showed. Japan is trying to fix its contact-tracing app after it failed to register new cases. Mask-wearing will be critical to reopening Australia's Victoria state, officials said.Key Developments:Global Tracker: Cases top 12.4 million; deaths surpass 559,000Wuhan shows the world how economies may recover‘Back to the nightmare' as virus shuts Hong Kong schoolsTesting bottlenecks are keeping states from tamping down virusBillionaire's empire unexpectedly thrives in BrazilTrump school-reopening gambit stokes fresh concernSubscribe to a daily update on the virus from Bloomberg's Prognosis team here. Click VRUS on the terminal for news and data on the coronavirus.Masks Key to Reopening Victoria (11:09 a.m. HK)Mask-wearing will be critical to reopening Australia's second-most populous state as it seeks to curb a second wave of infections, Victoria Premier Daniel Andrews said.Two million masks will be ordered and distributed to "priority groups," he said Saturday. The st

Yahoo BusinessJul 10, 2020
HHS allocates Gilead's COVID-19 drug remdesivir to four hardest hit states
The U.S. government has allocated more than 11,000 courses of Gilead Sciences Inc's COVID-19 treatment remdesivir to the four states now being hardest hit by the fast-spreading outbreak in the United States. The remdesivir is being distributed to Texas, Florida, California and Arizona on Friday and Monday, according to a U.S. Department of Health and Human Services (HHS) website https://www.phe.gov/emergency/events/COVID19/investigation-MCM/Pages/commercial-allocation-table.aspx. Remdesivir is in high demand as one of the only treatments so far shown to alter the course of COVID-19.


MarketWatch MarketPulseJul 10, 2020
Gold futures end lower for the session, but tally a 5th straight weekly gain
Gold futures ended lower on Friday, pulling back in the wake of the nearly nine-year high they reached earlier this week. Prices for the week, however, gained roughly 0.7%, as the spread of COVID-19 continued to raise the metal's appeal as a safe-haven investment. August gold fell $1.90, or 0.1%, to settle at $1,801.90 an ounce. Prices on Wednesday had settled at $1,820.60, the highest for a most-active contract since Sept. 14, 2011, according to FactSet data.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.


TRENDING TAGS
Trumprally Hampshire Goya Roger Stone
COVID-19Cases death Gilead remdesivir coronavirus
Stockmarket Buy Gilead Today Dow
coronaviruscases California latest Treatment release
StocksGilead Market Buy higher Right
TikTokAmazon employees security devices delete
Marketstock Stocks Gilead live updates
IncIssuer coronavirus CEO Interview cases
EmployeesAmazon TikTok delete their tells
CEOTrump Goya Interview President Inc

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC